You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Lewy and his inclusion bodies: Discovery and rejection
|
|---|---|
| Published in |
Dementia & Neuropsychologia, January 2017
|
| DOI | 10.1590/1980-57642016dn11-020012 |
| Pubmed ID | |
| Authors |
Eliasz Engelhardt, Marleide da Mota Gomes |
| Abstract |
Fritz Jacob Heinrich Lewy described the pathology of Paralysis agitans [Parkinson disease] and was the first to identify eosinophilic inclusion bodies in neurons of certain brain nuclei, later known as Lewy bodies, the pathological signature of the Lewy body diseases. In 1912, he published his seminal study, followed soon after by an update paper, and 10 years later, in 1923, by his voluminous book, where he exhaustively described the subject. The publication provided extensive information on the pathology of Paralysis agitans, and the entirely novel finding of eosinophilic inclusion bodies, which would become widely recognized and debated in the future. His discovery was acknowledged by important researchers who even named the structure after him. However, after his last publication on the issue, inexplicably, he never mentioned his histopathological discovery again. Despite several hypotheses, the reasons that led him to neglect (reject) the structure which he so preeminently described have remained elusive. |
Mendeley readers
The data shown below were compiled from readership statistics for 122 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 122 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 24 | 20% |
| Student > Bachelor | 20 | 16% |
| Student > Master | 18 | 15% |
| Student > Doctoral Student | 6 | 5% |
| Researcher | 5 | 4% |
| Other | 10 | 8% |
| Unknown | 39 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Neuroscience | 29 | 24% |
| Biochemistry, Genetics and Molecular Biology | 21 | 17% |
| Medicine and Dentistry | 9 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Nursing and Health Professions | 4 | 3% |
| Other | 13 | 11% |
| Unknown | 41 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 November 2023.
All research outputs
#8,537,346
of 25,382,440 outputs
Outputs from Dementia & Neuropsychologia
#185
of 328 outputs
Outputs of similar age
#145,808
of 421,709 outputs
Outputs of similar age from Dementia & Neuropsychologia
#12
of 23 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 328 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,709 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.